Construct: ORF ccsbBroad304_02634

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF004299.1_s304c1, BRDN0000402207
Derived from:
ccsbBroadEn_02634
DNA Barcode:
None
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
RABL2B (11158)

Vector Information:

Vector Backbone:
pLX_304
Pol II Cassette 1:
PGK-BlastR
Pol II Cassette 2:
CMV-ccsbBroad304_02634
Selection Marker:
BlastR
Visible Reporter:
n/a
Epitope Tag:
V5

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 11158 RABL2B RAB, member of RAS oncogene... NM_001003789.3 100% 100%
2 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130919.3 100% 100%
3 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130920.3 100% 100%
4 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130921.3 100% 100%
5 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350003.2 100% 100%
6 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350004.2 100% 100%
7 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028552.1 100% 100%
8 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028555.1 100% 100%
9 human 11158 RABL2B RAB, member of RAS oncogene... XM_024452147.1 100% 100%
10 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130922.3 99.5% 99.5% 408_409insGCA
11 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350005.2 99.5% 99.5% 408_409insGCA
12 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350006.2 99.5% 99.5% 408_409insGCA
13 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350007.2 99.5% 99.5% 408_409insGCA
14 human 11158 RABL2B RAB, member of RAS oncogene... NM_007081.4 99.5% 99.5% 408_409insGCA
15 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028556.1 99.5% 99.5% 408_409insGCA
16 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306158.2 99.2% 98.6% (many diffs)
17 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306159.2 99.2% 98.6% (many diffs)
18 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354412.2 99.2% 98.6% (many diffs)
19 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354413.2 99.2% 98.6% (many diffs)
20 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354414.2 99.2% 98.6% (many diffs)
21 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003213.1 99.2% 98.6% (many diffs)
22 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003214.1 99.2% 98.6% (many diffs)
23 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003215.1 99.2% 98.6% (many diffs)
24 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003216.1 99.2% 98.6% (many diffs)
25 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452575.1 99.2% 98.6% (many diffs)
26 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354416.2 98.8% 98.2% (many diffs)
27 human 11159 RABL2A RAB, member of RAS oncogene... NM_007082.5 98.8% 98.2% (many diffs)
28 human 11159 RABL2A RAB, member of RAS oncogene... NM_013412.4 98.8% 98.2% (many diffs)
29 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003220.1 98.8% 98.2% (many diffs)
30 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003222.1 98.8% 98.2% (many diffs)
31 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350016.2 97.4% 97.4% 506_523del
32 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350017.2 97.4% 97.4% 506_523del
33 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028551.1 97% 97% 408_409insGCA;503_520del
34 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354417.2 96.9% 96.5% (many diffs)
35 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003210.1 96.7% 96.1% (many diffs)
36 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003211.1 96.7% 96.1% (many diffs)
37 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003212.1 96.3% 95.7% (many diffs)
38 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350008.2 95.8% 95.8% 505_534del
39 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350009.2 95.8% 95.8% 505_534del
40 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350010.2 95.8% 95.8% 505_534del
41 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350011.2 95.8% 95.8% 505_534del
42 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350012.2 95.8% 95.8% 505_534del
43 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028543.1 95.8% 95.8% 505_534del
44 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028544.1 95.8% 95.8% 505_534del
45 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028546.1 95.8% 95.8% 505_534del
46 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130923.3 95.3% 95.3% 408_409insGCA;502_531del
47 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350013.2 95.3% 95.3% 408_409insGCA;502_531del
48 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350014.2 95.3% 95.3% 408_409insGCA;502_531del
49 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350015.2 95.3% 95.3% 408_409insGCA;502_531del
50 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028547.1 95.3% 95.3% 408_409insGCA;502_531del
51 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354405.2 95.1% 94.5% (many diffs)
52 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354406.2 95.1% 94.5% (many diffs)
53 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354407.2 95.1% 94.5% (many diffs)
54 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354408.2 95.1% 94.5% (many diffs)
55 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354409.2 95.1% 94.5% (many diffs)
56 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712208.3 95.1% 94.5% (many diffs)
57 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712209.3 95.1% 94.5% (many diffs)
58 human 11159 RABL2A RAB, member of RAS oncogene... XM_011510509.2 95.1% 94.5% (many diffs)
59 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003203.1 95.1% 94.5% (many diffs)
60 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003204.1 95.1% 94.5% (many diffs)
61 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003205.1 95.1% 94.5% (many diffs)
62 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003207.1 95.1% 94.5% (many diffs)
63 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306160.3 94.7% 94.1% (many diffs)
64 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354410.2 94.7% 94.1% (many diffs)
65 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452573.1 94.7% 94.1% (many diffs)
66 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306161.2 71.6% 71.1% (many diffs)
67 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354421.2 71.6% 71.1% (many diffs)
68 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354423.2 71.6% 71.1% (many diffs)
69 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003226.1 71.6% 71.1% (many diffs)
70 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354424.2 71.1% 70.7% (many diffs)
71 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354418.2 68.6% 68.2% (many diffs)
72 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354419.2 68.6% 68.2% (many diffs)
73 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003223.1 68.6% 68.2% (many diffs)
74 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354426.2 62.4% 62% (many diffs)
75 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354425.2 59.8% 59.4% (many diffs)
76 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003230.1 59.8% 59.4% (many diffs)
77 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354427.2 59.2% 56.3% (many diffs)
78 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354428.2 58.8% 55.8% (many diffs)
79 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452576.1 56.7% 53.9% (many diffs)
80 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028559.2 47.8% 42% (many diffs)
81 human 11159 RABL2A RAB, member of RAS oncogene... XR_002959036.1 27.2% (many diffs)
82 human 11159 RABL2A RAB, member of RAS oncogene... NR_148882.2 26.6% (many diffs)
83 human 11159 RABL2A RAB, member of RAS oncogene... NR_148881.2 26.6% (many diffs)
84 human 11159 RABL2A RAB, member of RAS oncogene... NR_148879.2 26.5% (many diffs)
85 human 11159 RABL2A RAB, member of RAS oncogene... NR_148880.2 22.7% (many diffs)
86 mouse 68708 Rabl2 RAB, member RAS oncogene fa... NM_026817.3 84.4% 80.7% (many diffs)
87 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521326.3 84% 80.3% (many diffs)
88 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521327.3 71.6% 69.4% (many diffs)
89 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521329.3 53.1% 48.9% (many diffs)
90 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_011245717.2 53.1% 48.9% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
66
ORF end:
753
ORF length:
687
Sequence:
1ggtctatata agcagagctc tctggctaac tgtcgggatc aacaagtttg tacaaaaaag
61ttggcatggc agaagacaaa accaaaccga gtgagttgga ccaagggaag tatgatgctg
121atgacaacgt gaagatcatc tgcctgggag acagcgcagt gggcaaatcc aaactcatgg
181agagatttct catggatggc tttcagccac agcagctgtc cacgtacgcc ctgaccctgt
241acaagcacac agccacggta gatggaagga ccatccttgt ggacttttgg gacacggcag
301gccaggagcg gttccagagc atgcatgcct cctactacca caaggcccac gcctgcatca
361tggtgtttga tgtacagagg aaagtcacct ataggaacct gagcacctgg tatacagagc
421ttcgggagtt caggccagag atcccatgca tcgtggtggc caataaaatt gatgcagaca
481taaacgtgac ccaaaaaagc ttcaattttg ccaagaagtt ctccctgccc ctgtatttcg
541tctcggctgc tgatggtacc aatgttgtga agctcttcaa tgatgcaatt cgattagctg
601tgtcttacaa acagaactcc caggacttca tggatgagat ttttcaggag ctcgagaact
661tcagcttgga gcaggaagag gaggacgtgc cagaccagga acagagcagc agcatcgaga
721ccccatcaga ggaggcggcc tctccccaca gctgcccaac tttcttgtac aaagtggttg
781gtaagcctat ccctaaccct ctcctcggtc tcgattctac gtagtaatga gctagcgcta
841accggtggcg cgttaagtcg acaatcaacc tctggatta

Download FASTA (ORF) (Full)